Journal of Leukocyte Biology BioLegend: Treg, Th17, Stem Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saeki, K.
Right arrow Articles by Yuo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saeki, K.
Right arrow Articles by Yuo, A.
(Journal of Leukocyte Biology. 2003;73:673-681.)
© 2003 by Society for Leukocyte Biology

Distinct involvement of cAMP-response element-dependent transcriptions in functional and morphological maturation during retinoid-mediated human myeloid differentiation

Kumiko Saeki, Koichi Saeki and Akira Yuo

Department of Hematology, Research Institute, International Medical Center of Japan, Tokyo

Correspondence: Akira Yuo, Department of Hematology, Research Institute, International Medical Center of Japan, 1-21-1, Toyama, Shinjuku-ku, Tokyo 162-8655, Japan. E-mail: yuoakira{at}ri.imcj.go.jp


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
We evaluated the involvement of cyclic adenosine monophosphate-response element (CRE)-dependent transcriptions in all-trans retinoic acid (ATRA)-induced myeloid differentiation using human monoblastic U937 cells. ATRA treatment caused an increment in the CRE-dependent transcription activity and induced a wide variety of differentiation phenotypes including functional and morphological maturation. Indeed, ATRA treatment induced the expression of CCAAT/enhancer-binding protein ß (C/EBPß), a CRE-dependent transcription factor important in monocytic differentiation, and the inhibition of CRE-enhancer activity by the expression of a dominant-negative CRE-binding protein (dn-CREB) abolished the induction of C/EBPß. Functional maturation, such as the enhancement of cell adhesion and respiratory burst activity, was dramatically suppressed by the expression of dn-CREB. In addition, the differentiation-dependent induction of an adhesion molecule (CD11b), the phagocyte oxidase required for respiratory burst, and the transcription factor PU.1 responsible for phagocyte oxidase induction were all abolished by dn-CREB. Surprisingly, morphological maturation, including nuclear convolution and cytoplasmic vacuolar formation, was augmented by dn-CREB. Under the same conditions, the differentiation-associated cell-growth arrest was not affected by the expression of dn-CREB. Our results clearly indicate that CRE-driven transcription plays at least three distinct roles during myeloid differentiation: It stimulates functional maturation but suppresses morphological maturation and has no effects on cell-growth arrest.

Key Words: CREB • C/EBP • PU.1 • adhesion • oxidative burst


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
During tissue and cell differentiation, specific molecular events, such as new gene induction and activation of various enzymes, take place in an ordered manner. For example, the ordered induction of homeobox genes plays essential roles during the formation of limbs in vertebrates [1 ] as well as hematopoiesis in mammalians [2 ]. However, it still remains elusive as to whether a simple hierarchical system or a complex system consisting of multiple, regulatory loops with redundancy and even mutual inhibition controls the differentiation process.

Cells acquire multiple phenotypes during differentiation: Some of them are essential for differentiation, and others seem to have no physiological significance. For example, during their maturation into granulocytes or monocytes, myeloblasts acquire respiratory burst activity essential for antibacterial reactions [3 ]. Conversely, differentiation-associated, morphological changes such as nuclear convolution do not seem to have any specific, physiological significance. It is of interest to clarify whether these two differentiation phenotypes with distinct biological significances are regulated by the same controlling system or individually regulated by distinct mechanisms.

Among the various inducers of differentiation, retinoid hormones such as all-trans retinoic acid (ATRA) are unique in that they can induce differentiation in a wide variety of cells [4 ], although the precise molecular events involved in retinoid hormone-mediated differentiation are largely unknown. Thus, clarification of the downstream molecular events involved in retinoic acid receptor (RAR)-mediated differentiation would be of use in understanding the common features of the differentiation process.

In addition to retinoid hormones, cyclic adenosine monophosphate (cAMP) analogs are potent inducers of differentiation in many cells including myelocytes [5 ]. In fact, cAMP-response element (CRE) is involved in the promoter activities of myeloid differentiation-associated genes such as CCAAT/enhancer-binding protein ß (C/EBPß) [6 ], interleukin-1ß [7 ], and prostaglandin-endoperoxide synthetase 2 [8 ]. It is interesting that CRE is also involved in cell proliferation [9 ], a completely distinct phenomenon to differentiation. Thus, elucidation of the in vivo involvement of CRE in myeloid differentiation will be of help in understanding the regulatory systems at work during the proliferation and differentiation processes in hematopoietic cells.

In the present study, we established a model system in which cAMP-dependent signals were specifically blocked by the expression of a dominant-negative CRE-binding protein (dn-CREB). Using this model, we examined the molecular mechanism of retinoid hormone-induced myeloid differentiation and the involvement of CRE-dependent transcription.

We show that CRE-dependent transcriptions play two "contrasting" roles during human myeloid differentiation: namely, positively regulating cell adhesion and respiratory burst activity but negatively regulating morphological maturation such as nuclear convolution and cytoplasmic vacuolar formation. This finding indicates that a dissociation in the regulatory system exists between physiological and morphological maturation. The biological significance of these phenomena is also discussed.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Cells, plasmids, and reagents
U937 cells were maintained in RPMI-1640 medium (Life Technologies, Grand Island, NY) supplemented with 10% heat-inactivated fetal bovine serum (FBS; JRH Bioscience, Lenexa, KS). The coding region of CREB cDNA was isolated by cutting pCG-CREB [10 ] with XbaI (Takara Shuzo Co. Ltd., Shiga, Japan) and BamHI (Takara Shuzo Co. Ltd.), the ends of which had been blunted with the Klenow fragment. The pCI-anti-CREB was constructed by inserting CREB cDNA into a pCI-neo vector at the SmaI site (Clontech Laboratory, Palo Alto, CA) in the antisense direction. The pCI-dn-CREB was constructed by inserting the coding region of KCREB [11 ] cDNA from pCG-KCREB [12 ] into the SmaI site of a pCI-neo vector (Clonetech Laboratory) in the sense direction. Next, 1 µg pCI-neo, pCI-anti-CREB, or pCI-KCREB was transfected into 2 x 106 U937 cells using Lipofectamine Plus reagent (Life Technologies). After a 48-h incubation, selection was made with 350 µg/ml G418 (Wako Pure Chemical Industries, Osaka, Japan) in 750 mm2 flasks for 5 days. Further selection was made under limiting dilution conditions using 96-well dishes. The level of CREB protein expression for each clone was examined by Western blotting. ATRA (Sigma Chemical Co., St. Louis, MO) was solubilized in ethanol as a 1-mM stock solution and was kept at -20°C before being added to cells at a final concentration of 1 µM.

Morphological examination
The cells were washed with phosphate-buffered saline (PBS) and fixed on glass slides using a cytospin apparatus (Cytospin2, Shandon, Pittsburgh, PA) before being stained with Wright-Giemsa solution (Muto Pure Chemical Co., Ltd., Tokyo, Japan).

Examination of differentiation marker proteins by flow cytometry analysis
Cells were cultured at a density of 1 x 105/ml in 24-well dishes (1 ml/well) with 1 µl ethanol or 1 µl 1 mM ATRA (final concentration, 1 µM). After a 3-day incubation at 37°C, the cells were collected and washed with PBS containing 5% FBS and 0.05% sodium azide. They were then incubated with fluorescein isothiocyanate-conjugated mouse monoclonal anti-CD11b or -CD54 antibody (Caltag Laboratories, An-Der-Grub, Austria), and the expression of each protein was analyzed by FACSCalibur (Becton Dickinson, Mountain View, CA).

Antiserum and Western blot analysis
For Western blotting, 5 x 105 cells were lysed in 20 µl 1x Laemmli’s sample buffer and were boiled before being applied to a 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel (5x104 cells/10 µl/lane). After electrophoresis, the proteins were transferred to a polyvinylidene difluoride membrane (Millipore Co., Bedford, MA). The first antibody reactions were performed using anti-CREB (New England Biolabs, Beverly, MA), anti-p67phox (Santa Cruz Biotechnology, Santa Cruz, CA), anti-p47phox (Santa Cruz Biotechnology), anti-PU.1 (Santa Cruz Biotechnology), or anti-C/EBPß (Santa Cruz Biotechnology) antibody. The second antibody reactions were performed using horseradish peroxidase (HRP)-conjugated anti-mouse and anti-rabbit monoclonal antibodies (mAb; New England Biolabs) or an HRP-conjugated anti-sheep mAb (Chemicon, Temecula, CA). The final detection procedure was performed using SuperSignal West Dura extended duration substrate (Pierce, Rockford, IL) followed by exposure to Hyperfilm (Amersham International PLC, Buckinghamshire, UK).

Reverse transcription-polymerase chain reaction (RT-PCR)
mRNA was extracted from 8 x 107 cells with a Fast Track 2.0 kit (Invitrogen, Carlsbad, CA) and was then suspended in 50 µl 0.1% diethyl pyrocarbonate in water. A 1-µl aliquot of the mRNA solution was used for the RT reaction with avian myloblastosis virus RT XL (Takara Shuzo Co. Ltd.), and the product was then suspended in 20 µl 0.1% diethyl pyrocarbonate in water. The PCR procedure was performed using a DNA Thermal Cycler PJ2000 (PerkinElmer Corp., Foster City, CA) under the following conditions: 94°C, 30 s; 55°C, 1 min; 72°C, 1 min for 30 cycles. For detection of the transgene product, the sequences 5'-CGCGTGGTACCTCTAGAGTCGACC-3' from the promoter region in the pCI-neo vector and 5'-CATTAACCCTCACTAAAGGGAAG-3' from 3' the flanking region in the pCI-neo vector were used as primers. For detection of the ß2-microglobulin message, sense primer (5'-GTGGAGCATTCAGACTTGTC-3') and antisense primer (5'-CTGCTTACATGTCTCGATCC-3') were used. The product was separated by agarose gel electrophoresis, and the DNA (product sizes: transgenes, 1.1 kbp; ß2-microglobulin, 160 bp) was visualized by ethidium bromide staining. For the molecular markers, Smart Ladder (0.2–10 kbp) was used (Wako Pure Chemical Industries).

Nitroblue tetrazolium (NBT)-reducing activity
Cells were cultured at a density of 1 x 105/ml in 24-well dishes (1 ml/well) with 1 µl ethanol or 1 µl 1 mM ATRA (final concentration, 1 µM). After a 3-day incubation at 37°C, 5 x 105 cells were collected and washed before being suspended in 1 ml RPMI-1640 medium. Next, 1 ml NBT solution (1 mg/ml) was added, and the cells were incubated for 25 min at 37°C with 100 ng 12-O-tetradecanoylphorbol 13-acetate (TPA) and were finally washed once with PBS. The numbers of NBT-positive cells were counted with a light microscope (Olympus Optical Co. Ltd., Tokyo, Japan).

Transfection and luciferase assay
The pCRE-firefly luciferase reporter (fLuc) was constructed by inserting a 36-bp CRE-enhancer fragment (CTC GGG GCG CCT CCT TGG CTGACG TCA GAG AGA GAG) from the somatostatin gene [10 ] into the NheI/XhoI site of pGL2-Basic fLuc (Nippon Gene Co. Ltd., Tokyo, Japan) together with a herpes simplex virus thymidine kinase (TK) promoter fragment from pRL-TK (Promega, Madison, WI) into the BglII site. pCRE-Luc (20 µg) and 0.4 µg pRL-simian virus 40 (SV40), a SV40 enhancer-driven Renilla luciferase reporter (Promega), were suspended in 194.4 µl water to which 5.6 µl ethoxylated polyethylenimine (EPEI; Gene Tools, LLC, Philomath, OR) was added and mixed immediately. The DNA/EPEI solution was incubated at room temperature for 25 min, after which 3.8 ml serum-free medium was added. A 2-ml aliquot of the DNA/EPEI solution was mixed with 2 x 106 cells, previously washed once with serum-free medium. The cells were placed in a 24-well dish (0.5 ml/well) and incubated for 3 h at 37°C, and then the medium was replaced with 1 ml serum-containing medium. After incubation at 37°C for another 2 h, the cells were divided into two groups. They were transferred into a six-well dish (4 ml/well) to which 4 µl ethanol or 4 µl ATRA solution (1 mM) was added. After a 2-day incubation at 37°C, cell lysate was prepared, and the luciferase assay was performed with the Dual-LuciferaseTM reporter assay system (Promega). The CRE activity was assessed by normalizing the fLuc activity with that of the RL activity. There were no significant differences in SV40-enhancer activities among the three lines.

Statistical analysis
The Student’s t-test was used to determine statistical significance. A P value of <0.01 was considered significant.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Establishment of U937 transformants expressing a dn-CREB
To assess the contribution of CRE-dependent transcriptions on the ATRA-induced myeloid differentiation, we constructed human monoblastic U937 transformant lines stably expressing a dn-CREB, which does not bind DNA but dimerizes with CREB/activation transcription factor (ATF) family proteins and thus inhibits CRE-dependent transcriptions [11 ]. For control, an empty vector with a sole neomycin-resistant gene expression unit {cytolytic T lymphocyte [control (CTL)]} or a vector in which the coding region of CREB cDNA was inserted in the antisense direction together with a neomycin-resistant gene expression unit [CTL (anti)] was transfected. We did not transfect the expression vector of CREB per se, as overexpression of CREB results in cell death, as we previously reported [12 ]. After the preselection in the presence of neomycin, clones were further selected by Western blotting using an anti-CREB antiserum.

According to the results of the Western blot analysis, we selected three clones for each line: clone-1, clone-2, and clone-3 for CTL (neo); clone-1, clone-2, and clone-5 for dn-CREB with a high-protein expression as a result of transgene-derived dn-CREB (Fig. 1A ); and clone-1, clone-2, and clone-9 for CTL (anti) with reduced CREB as a result of the antisense message expression (Fig. 1B) . All these clones showed equivalent levels of ß-tublin expression (Fig. 1C) , confirming that the difference in protein-expression level was specific to CREB. The expression of the transgene-derived message was further confirmed by RT-PCR using transgene-specific probes (Fig. 1D) . We also checked the growth of each line, as cAMP-mediated signals are involved in cell proliferation [9 ] as well as cell viability [12 ]. We found that the viable cell number of dn-CREB lines was significantly smaller than that of CTL (neo) lines (Fig. 2 ). Conversely, the viable cell number of CTL (anti) lines was almost identical to that of CTL (neo) lines (Fig. 2) , probably as a result of compensation by other CREB/ATF family members. These findings further support that dn-CREB protein is in fact expressed in the three clones in dn-CREB lines. Thus, we performed the following experiment using these nine clones.



View larger version (29K):
[in this window]
[in a new window]
  		Figure 1. The construction and evaluation of U937 transformant lines. (A–C) Western blot analysis. Cell lysates were prepared from neomycin-selected clones of U937 cells after transfection with an expression vector for the (A, B and C) CTL (neo), an expression vector for (A and C) dn-CREB, and an expression vector for the (B and C) CTL (anti). An aliquot of each lysate was used for Western blot analysis (5x104 cells/lane) with the anti-CREB antibody (A and B) or anti-ß-tublin antibody (C). (D) RT-PCR analysis. The mRNA was extracted from three clones of the CTL (neo) lines (clone-1, clone-2, and clone-3); three CTL (anti) lines (clone-1, clone-2, and clone-9); and three dn-CREB lines (clone-1, clone-2, and clone-5); 1 µg was used for RT-PCR with primers derived from the promoter region and the 3' noncoding region of the pCI-neo vector (upper) or ß2-microglobulin (lower). The 1177-bp PCR products derived from the transgene were detected only in the CTL (anti) and dn-CREB lines (upper), and the 160-bp PCR products derived from ß2-microglobulin were detected in all lines (lower). The transgene product in CTL (neo) lines was only 56 bp and was not visible in this gel electrophoresis.

 


View larger version (36K):
[in this window]
[in a new window]
  		Figure 2. The involvement of CRE in cell growth. Three clones from the CTL (neo) lines (closed square, diamond, and rectangle), CTL (anti) lines (open square, diamond, and rectangle), and dn-CREB lines (dotted square, diamond, and rectangle) were cultured at a density of 2 x 104/ml in 24-well dishes. The number of viable cells was then counted over time. The experiment was performed in triplicate, and the average cell number is presented. Note that the number of viable cells in dn-CREB lines was significantly low compared with that of CTL (neo) lines.

 
CRE-driven transcription activity of U937 transformants with or without ATRA treatment
We then compared the CRE-driven transcription activity with or without ATRA treatment in U937 transformants. We found that CRE-driven transcription was up-regulated by ATRA treatment in CTL (neo) and CTL (anti) lines but was down-regulated in dn-CREB lines (Fig. 3A ). Consistent with these results, the ATRA-dependent induction of C/EBPß, a CRE-driven transcription factor [6 ] important for monocytic differentiation [13 ], was significantly attenuated in dn-CREB lines compared with CTL (neo) and CTL (anti) lines (Fig. 3B) . The intact CRE activation in CTL (anti) lines is likely a result of compensation by the CREB/ATF family proteins.



View larger version (19K):
[in this window]
[in a new window]
  		Figure 3. CRE-dependent transcription. (A) Luciferase assay. Approximately 2 x 106 cells of CTL (neo) clone-1, CTL (anti) clone-1, and dn-CREB clone-1 were cotransfected with 20 µg CRE-enhancer-containing fLuc reporter together with 0.4 µg SV40 enhancer-containing RL reporter. Two hours after transfection, cells were treated with ethanol (EtOH) or 1 µM ATRA. After a 2-day incubation, the luciferase assay was performed. The CRE-enhancer activity was normalized by SV40-enhancer activity; the latter was used as an internal control for transfection efficiency. Open bars indicate the CRE-enhancer activities of ethanol-treated samples, and hatched bars indicate those of ATRA-treated ones. The data are expressed as mean ± SD of three independent experiments. Note that CRE activities in dn-CREB lines were significantly reduced compared with those in CTL (neo) lines in ethanol- and ATRA-treated cases. The results of the other two clones for each line were similar (data not shown). (B) C/EBPß induction. Approximately 1 x 105 cells of the three clones from the CTL (neo) lines, CTL (anti) lines, and dn-CREB lines were treated with or without ATRA. After a 3-day incubation, cell lysates were prepared, and Western blot analysis was performed using the anti-C/EBPß antibody.

 
Thus, expression of dn-CREB causes impairment of CRE-enhancer activity and abolishes C/EBPß gene induction during ATRA-induced monocytic differentiation.

Phenotype analysis of U937 transformants during functional maturation
We investigated the differentiation parameters regarding functional maturation. First, we examined the differentiation-associated cell adhesion and aggregation by light microscopic observation 3 days after ATRA treatment. As shown in Figure 4A , ATRA-induced cell adhesion and aggregation were significantly attenuated in dn-CREB lines. Moreover, differentiation-dependent induction of an adhesion molecule, CD11b, was significantly attenuated in dn-CREB lines compared with CTL (neo) and CTL (anti) lines (Fig. 4B , left). Conversely, the basal expression of CD54 was severely blocked in dn-CREB lines, and ATRA treatment up-regulated the surface CD54 expression in dn-CREB lines to an almost equivalent level to that observed in CTL (neo) and CTL (anti) lines (Fig. 4B , right).



View larger version (49K):
[in this window]
[in a new window]
  		Figure 4. ATRA-induced cell adhesion. (A) Cell aggregation. Aliquots of the CTL (neo) line (clone-3; left), CTL (anti) line (clone-9; center), and dn-CREB line (clone-5; right) were cultured at a density of 1 x 105 cells/ml in 24-well dishes before being treated with 1 µl ethanol (EtOH) or 1 µM ATRA. Cell aggregation was examined using an inverted light microscope after a 3-day incubation (original magnification, x40). Note the loss of cell aggregation in the dn-CREB line (lower right). The other two clones of each transformant, CTL (neo), CTL (anti), or dn-CREB, showed similar results (data not shown). (B) CD11b and CD54 expression. Aliquots of the CTL (neo) line (clone-3; top), CTL (anti) line (clone-9; middle), and dn-CREB line (clone-5; bottom) were cultured at a density of 1 x 105 cells/ml in 24-well dishes before being treated with 1 µl ethanol or 1 µM ATRA. After a 3-day incubation, the surface expression of CD11b (left) or CD54 (right) was determined by flow cytometry analysis. Thin lines indicate the results of isotype-control immunoglobulin G staining. Bold lines represent anti-CD11b (left) or anti-CD54 (right) antibody staining of ethanol-treated samples, and dotted lines represent ATRA-treated samples. The other two clones of each transformant line showed similar results (data not shown).

 
Next, we studied the differentiation-dependent enhancement in respiratory burst activity by measuring the NBT-reducing potential 3 days after ATRA treatment. As shown in Figure 5A , the TPA-triggered respiratory burst activity was significantly suppressed in dn-CREB lines compared with CTL (neo) and CTL (anti) lines. In accordance with this, ATRA-induced expression of p67phox, the dose-limiting component of phagocyte reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase [14 ], was strongly reduced in dn-CREB lines (Fig. 5B , upper). Moreover, ATRA-induced expression of p47phox, another component of NADPH oxidase, was almost completely blocked in dn-CREB lines (Fig. 5B , lower). As for p22phox and gp91phox, membrane components of NADPH oxidase, we found no significant differences among CTL (neo), CTL (anti), and dn-CREB lines after ATRA treatment (data not shown).



View larger version (30K):
[in this window]
[in a new window]
  		Figure 5. ATRA-induced respiratory burst activity. (A) NBT reduction activity. The three CTL (neo) lines, CTL (anti) lines, and dn-CREB lines were treated with 1 µM ATRA. After a 3-day incubation, the cells were collected and incubated with TPA for 25 min. The NBT reduction-positive cells were then counted under an inverted light microscopy. The data are expressed as mean ± SD of three independent experiments. Note that NBT-reducing activities in dn-CREB lines were significantly reduced compared with those in CTL (neo) lines. Nontreated cells and cells treated with ethanol alone did not show any detectable NBT reduction (data not shown). (B and C) The expression of p67phox, p47phox, and PU.1. The three CTL (neo) lines, CTL (anti) lines, and dn-CREB lines were treated with ethanol or ATRA. After a 3-day incubation, the cell lysates were prepared, and Western blot analysis was performed using anti-p67phox and anti-p47phox antibodies (B) or an anti-PU.1 antibody (C).

 
We further examined the expression of PU.1, an important transcriptional factor for p67phox and p47phox gene induction [15 ,16 ]. The PU.1 expression was up-regulated after ATRA treatment in CTL (neo) and CTL (anti) lines, and PU.1 gene induction was almost completely blocked in dn-CREB lines (Fig. 5C) .

Thus, CRE-dependent transcriptions contribute to the induction of respiratory burst activity by up-regulating p67phox and p47phox expression through PU.1 gene induction.

Morphological findings of U937 transformants during differentiation
We then evaluated differentiation-dependent morphological alterations. In CTL (neo) lines, no apparent changes in nuclear or cytoplasmic morphologies were observed, although there was a reduction in total cell size (Fig. 6A , left). In CTL (anti) lines, mild nuclear convolution was detected as well as a reduction in cell size, but no apparent cytoplasmic vacuolar formation was detected (Fig. 6A , center). In contrast, dn-CREB lines showed remarkable changes, including nuclear convolution and multiple cytoplasmic vacuole formation, as well as a reduction in cell size (Fig. 6A , lower right). It is interesting that nuclear convolution was detected even without ATRA treatment in dn-CREB lines (Fig. 6A , upper right). Thus, the inhibition of CRE-dependent transcription resulted in the acceleration of morphological maturation with or without ATRA treatment.



View larger version (29K):
[in this window]
[in a new window]
  		Figure 6. ATRA-induced morphological changes. (A) Wright-Giemsa staining. Aliquots of the CTL (neo) line (clone-3; left), CTL (anti) line (clone-9; center), and dn-CREB line (clone-5; right) were cultured at a density of 1 x 105 cells/ml in a 24-well dish before being treated with 1 µl ethanol (EtOH) or 1 µM ATRA. After a 3-day incubation, the cells were fixed on slide glasses and stained with Wright-Giemsa solution. Cell morphology was observed using a light microscope (original magnification, x1000). The other two clones of each transformant line showed similar results (data not shown). (B) Flow cytometry analysis. Aliquots of the CTL (neo) clone-3 (top), CTL (anti) clone-9 (middle), and dn-CREB clone-5 (bottom) were cultured at a density of 1 x 105 cells/ml in 24-well dishes before being treated with 1 µl ethanol or 1 µM ATRA. After a 3-day incubation, the cells were fixed with 1% paraformaldehyde, and two-dimensional flow cytometry analysis [x-axis, forward-scattered light (FSC); y-axis, side-scattered light (SSC)] was performed. The numbers indicate the percentage of cells located in the FSC-low/SSC-high area. Similar results were obtained from the other two clones of each transformant line (data not shown).

 
To quantify the morphological changes during ATRA-induced differentiation, we estimated SSC values by flow cytometry analysis as a marker of the morphological complexity associated with cytoplasmic vacuole formation. As shown in Figure 6B , ATRA-treated dn-CREB lines showed markedly higher SSC values than ATRA-treated CTL (neo) and CTL (anti) lines [percentages of cells with high SSC values after ATRA treatment are 0.8% in CTL (neo), 1.1% in CTL (anti), and 20.2% in dn-CREB lines]. Moreover, dn-CREB lines showed higher SSC values than CTL (neo) and CTL (anti) lines even without ATRA treatment [2.7% in dn-CREB lines vs. 0.6% in CTL (neo) and 0.4% in CTL (anti) lines]. These findings are almost compatible with the findings in Figure 6A .

Thus, CRE enhancer is required for the inhibition of morphological maturation during myeloid differentiation.

Differentiation-dependent growth arrest in U937 transformants
As ATRA has antiproliferative activity on myeloid cells [3 , 4 ], we finally examined the involvement of CRE-dependent transcription in differentiation-associated cell-growth arrest. Time-course analysis of the numbers of viable cells was conducted with ATRA treatment in CTL (neo), CTL (anti), and dn-CREB lines. We found that the growth rate was reduced by approximately 20% after ATRA treatment in all three lines and could not detect any significant differences among them (Fig. 7 ).



View larger version (17K):
[in this window]
[in a new window]
  		Figure 7. Differentiation-associated growth inhibition. Aliquots of the CTL (neo) clone-3 (left), CTL (anti) clone-9 (center), and dn-CREB clone-5 (right) were cultured at a density of 1 x 105 cells/ml in 24-well dishes before being treated with 1 µl ethanol (EtOH) or 1 µM ATRA. Viable cell numbers were counted over a time course. The data are expressed as mean ± SD of three independent experiments. The other two clones of each transformant line showed similar results (data not shown).

 
Thus, CRE-dependent transcriptions are not required for ATRA-induced cell-growth arrest.


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
We showed the divergent roles of CRE-dependent transcriptions during ATRA-induced human myeloid differentiation and demonstrated their requirement in differentiation-dependent cell adhesion and respiratory burst activity. By contrast, CRE-dependent transcriptions suppress differentiation-dependent, morphological changes. In addition, we found that CRE-dependent transcriptions are not involved in differentiation-associated growth arrest. To our knowledge, this is the first report to show the different roles of CRE-dependent transcriptions in the development of each differentiation phenotype.

The dn-CREB lines showed insufficient inductions of p67phox, p47phox, and PU.1 by ATRA treatment. Although PU.1 is also an activator of the gp91phox promoter, we could not find any enhancement of the gp91phox protein expression in ATRA-treated CTL (neo), CTL (anti), and dn-CREB lines. We could also not detect any significant differences in the levels of gp91phox protein expression even after ATRA treatment among the three lines. Moreover, p67phox is the dose-limiting component of phagocyte NADPH oxidase [14 ]. Thus, we speculate that the molecular basis for reduced respiratory burst activity in dn-CREB lines may be the insufficient induction of p67phox as a result of failed PU.1 induction [15 , 16 ]. The defects in PU.1 induction may also be the reason for the insufficient CD11b induction in ATRA-treated dn-CREB lines [17 ]. At present, however, we do not know the precise molecular mechanism by which CRE-dependent transcriptions contribute to PU.1 gene induction. There is no CRE consensus sequence in the PU.1 promoter region, at least up to -30 bp upstream from the transcriptional initiation site [18 ]. Thus, the CRE enhancer may function at a more upstream region in the PU.1 promoter, or alternatively, CRE-dependent transcriptions may induce a specific transcription factor responsible for activation of the PU.1 promoter. Further investigations are required to determine the exact mechanism.

The accelerated, morphological maturation in dn-CREB lines under ATRA-treated and nontreated conditions indicates that CRE-dependent transcriptions play a role in inhibiting the basal as well as differentiation-associated, morphological alterations. Although the molecular mechanism involved in morphological maturation is still elusive, our findings at least show that CRE-dependent transcriptions negatively regulate morphological maturation. The reason CRE-dependent transcription inhibits morphological maturation may be a result of the fact that CRE-dependent transcription works in cell proliferation [9 ] where morphological alterations must not occur. Thus, other molecular events, which work more strongly than CRE-dependent transcription, would transmit signals for morphological alterations during differentiation. Further investigations will elucidate the precise molecular mechanism of morphological maturation.

As we showed in Figure 7 , CRE-dependent transcriptions are not required for differentiation-associated growth arrest. This is in a clear contrast to the fact that CRE-dependent transcriptions play some roles in baseline cell proliferation (Fig. 2) , probably by inducing the genes for cyclin D [19 ] and cyclin A [20 ]. Thus, distinct mechanisms are at work in growth regulation under undifferentiated and differentiated conditions. It has been reported that interferon regulatory factor (IRF) is involved in differentiation-associated growth arrest [21 ]. Thus, the function of IRF-dependent transcriptions is superior to CRE-dependent transcriptions regarding growth regulation, the former playing a dominant role in ATRA-induced growth arrest.

Our data concerning the involvement of CRE-dependent transcriptions in myeloid differentiation and proliferation are summarized in Figure 8 . As we showed, ATRA-mediated signals might be divided into three categories: CRE-activated, CRE-inhibited, and CRE-independent pathways. Among these, the signal regulating CD54 expression was rather unique in that CRE-dependent transcriptions are essential for its basal expression, but retinoic acid can transmit signals by bypassing CRE-dependent signaling during differentiation. This finding indicates that there is a redundancy in the regulation of CD54 expression.



View larger version (20K):
[in this window]
[in a new window]
  		Figure 8. Model of molecular signaling during ATRA-induced differentiation. RXR, Retinoid-X receptor.

 
CRE-dependent transcription is unique in that it plays roles in a number of important biological reactions including cell proliferation [9 ], death [12 ], and differentiation. This is not surprising, as the CRE sequence is so abundant throughout the whole genome that it can be detected in one-third of all the promoter regions, making it almost as frequent as the TATA sequence (personal communication by Dr. Sumio Sugano, University of Tokyo, Japan). Our model further suggests that differentiation is not a simple hierarchical process but a complex one in which redundant and even contradictory, regulatory loops are included. This suggests that proliferation and differentiation are not entirely independent phenomena but share a common molecular process.

Using in vitro cultured cells, we have shown the involvement of CRE-dependent transcription in myeloid differentiation, although the in vivo significance of our findings remains unclear. The involvement of CREB-binding factors, such as CREB-binding protein [22 ] and Tax [23 ], in the development of acute leukemia suggests a possible involvement of CRE-dependent transcription in in vivo hematopoietic differentiation. Recently, it was reported that CREB-/-/ATF-1-/- double-knockout mice are embryonically lethal at the morula stage [24 ]. Thus, it may be somewhat difficult to understand the requirement of CRE-dependent transcriptions during hematopoiesis using this murine system. In this sense, our system would be very useful, providing valuable information concerning the functions of CRE-dependent transcriptions in human hematopoiesis. Further investigations to clarify the in vivo importance of CRE-dependent transcriptions during myeloid development will be of help in establishing a novel therapy for hematopoietic disorders.


   ACKNOWLEDGEMENTS
 
This work was supported by a Grant-in-Aid for the Second Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare, Japan. Authors thank Mrs. Noriko Kobayashi for technical assistance.

Received October 29, 2002; revised January 21, 2003; accepted January 24, 2003.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Zakany, J., Duboule, D. (1999) Hox genes in digit development and evolution Cell Tissue Res. 296,19-25[CrossRef][Medline]
  2. Lawrence, H. J., Sauvageau, G., Humphries, R. K., Largman, C. (1996) The role of HOX homeobox genes in normal and leukemic hematopoiesis Stem Cells 14,281-291[Abstract]
  3. Yuo, A. (2001) Differentiation, apoptosis, and function of human immature and mature myeloid cells: intracellular signaling mechanism Int. J. Hematol. 73,438-452[Medline]
  4. Evans, T. R., Kaye, S. B. (1999) Retinoids: present role and future potential Br. J. Cancer 80,1-8[CrossRef][Medline]
  5. Patel, T. B., Du, Z., Pierre, S., Cartin, L., Scholich, K. (2001) Molecular biological approaches to unravel adenylyl cyclase signaling and function Gene 269,13-25[CrossRef][Medline]
  6. Niehof, M., Manns, M. P., Trautwein, C. (1997) CREB controls LAP/C/EBPß transcription Mol. Cell. Biol. 17,3600-3613[Abstract]
  7. Gray, J. G., Chandra, G., Clay, W. C., Stinnett, S. W., Haneline, S. A., Lorenz, J. J., Patel, I. R., Wisely, G. B., Furdon, P. J., Taylor, J. D. A. (1993) CRE/ATF-like site in the upstream regulatory sequence of the human interleukin 1 ß gene is necessary for induction in U937 and THP-1 monocytic cell lines Mol. Cell. Biol. 13,6678-6689[Abstract/Free Full Text]
  8. Xie, W., Herschman, H. R. (1996) Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum J. Biol. Chem. 271,31742-31748[Abstract/Free Full Text]
  9. Jean, D., Bar-Eli, M. (2000) Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family Mol. Cell. Biochem. 212,19-28[CrossRef][Medline]
  10. Saeki, K., Yuo, A., Takaku, F. (1999) Cell-cycle-regulated phosphorylation of cAMP response element-binding protein: identification of novel phosphorylation sites Biochem. J. 338,49-54
  11. Walton, K. M., Rehfuss, R. P., Chrivia, J. C., Lochner, J. E., Goodman, R. H. (1992) A dominant repressor of cyclic adenosine 3', 5'-monophosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo Mol. Endocrinol. 6,647-655[Abstract]
  12. Saeki, K., Yuo, A., Suzuki, E., Yazaki, Y., Takaku, F. (1999) Aberrant expression of cAMP-response-element-binding protein (‘CREB’) induces apoptosis Biochem. J. 343,249-255
  13. Yamanaka, R., Lekstrom-Himes, J., Barlow, C., Wynshaw-Boris, A., Xanthopoulos, K. G. (1998) CCAAT/enhancer binding proteins are critical components of the transcriptional regulation of hematopoiesis (Review) Int. J. Mol. Med. 1,213-221[Medline]
  14. Levy, R., Rotrosen, D., Nagauker, O., Leto, T. L., Malech, H. L. (1990) Induction of the respiratory burst in HL-60 cells. Correlation of function and protein expression J. Immunol. 145,2595-2601[Abstract]
  15. Kautz, B., Kakar, R., David, E., Eklund, E. A. (2001) SHP1 protein-tyrosine phosphatase inhibits gp91phox and p67phox expression by inhibiting interaction of PU.1, IRF1, interferon consensus sequence-binding protein, and CREB-binding protein with homologous Cis elements in the CYBB and NCF2 genes J. Biol. Chem. 276,37868-37878[Abstract/Free Full Text]
  16. Li, S. L., Schlegel, W., Valente, A. J., Clark, R. A. (1999) Critical flanking sequences of PU.1 binding sites in myeloid-specific promoters J. Biol. Chem. 274,32453-32460[Abstract/Free Full Text]
  17. Panopoulos, A. D., Bartos, D., Zhang, L., Watowich, S. S. (2002) Control of myeloid-specific integrin alpha Mbeta 2 (CD11b/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU.1 J. Biol. Chem. 277,19001-19007[Abstract/Free Full Text]
  18. Chen, H., Ray-Gallet, D., Zhang, P., Hetherington, C. J., Gonzalez, D. A., Zhang, D. E., Moreau-Gachelin, F., Tenen, D. G. (1995) PU.1 (Spi-1) autoregulates its expression in myeloid cells Oncogene 11,1549-1560[Medline]
  19. Herber, B., Truss, M., Beato, M., Muller, R. (1994) Inducible regulatory elements in the human cyclin D1 promoter Oncogene 9,1295-1304[Medline]
  20. Desdouets, C., Matesic, G., Molina, C. A., Foulkes, N. S., Sassone-Corsi, P., Brechot, C., Sobczak-Thepot, J. (1995) Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM Mol. Cell. Biol. 15,3301-3309[Abstract]
  21. Abdollahi, A., Lord, K. A., Hoffman-Liebermann, B., Liebermann, D. A. (1991) Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition Cell Growth Differ. 2,401-407[Abstract]
  22. Borrow, J., Stanton, V. P., Jr, Andresen, J. M., Becher, R., Behm, F. G., Chaganti, R. S., Civin, C. I., Disteche, C., Dube, I., Frischauf, A. M., Horsman, D., Mitelman, F., Volinia, S., Watmore, A. E., Housman, D. E. (1996) The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein Nat. Genet. 14,33-41[CrossRef][Medline]
  23. Yin, M. J., Gaynor, R. B. (1996) Complex formation between CREB and Tax enhances the binding affinity of CREB for the human T-cell leukemia virus type 1 21-base-pair repeats Mol. Cell. Biol. 16,3156-3168[Abstract]
  24. Bleckmann, S. C., Blendy, J. A., Rudolph, D., Monaghan, A. P., Schmid, W., Schutz, G. (2002) Activating transcription factor 1 and CREB are important for cell survival during early mouse development Mol. Cell. Biol. 22,1919-1925[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
D. Sawka-Verhelle, L. Escoubet-Lozach, A. L. Fong, K. D. Hester, S. Herzig, P. Lebrun, and C. K. Glass
PE-1/METS, an Antiproliferative Ets Repressor Factor, Is Induced by CREB-1/CREM-1 during Macrophage Differentiation
J. Biol. Chem., April 23, 2004; 279(17): 17772 - 17784.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saeki, K.
Right arrow Articles by Yuo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saeki, K.
Right arrow Articles by Yuo, A.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS